{# Audit 04/10/2026 : « autre » n'est pas un code de langue ; SPHAERO n'est pas l'éditeur des documents qu'elle héberge ou référence. #} {# citation_pdf_url doit mener à un PDF : un lien vers une page DOI est pénalisé par Google Scholar (avant : tout lien externe). #}
Accès ouvert · CC BY

Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis

Article scientifique 2018 Anglais

Résumé

We investigated host-derived biomarkers that were previously identified in QuantiFERON supernatants, in a large pan-African study. We recruited individuals presenting with symptoms of pulmonary TB at seven peripheral healthcare facilities in six African countries, prior to assessment for TB disease. We then evaluated the concentrations of 12 biomarkers in stored QuantiFERON supernatants using the Luminex platform. Based on laboratory, clinical and radiological findings and a pre-established algorithm, participants were classified as TB disease or other respiratory diseases(ORD). Of the 514 individuals included in the study, 179(34.8%) had TB disease, 274(51.5%) had ORD and 61(11.5%) had an uncertain diagnosis. A biosignature comprising unstimulated IFN-γ, MIP-1β, TGF-α and antigen-specific levels of TGF-α and VEGF, identified on a training sample set (n = 311), validated by diagnosing TB disease in the test set (n = 134) with an AUC of 0.81(95% CI, 0.76-0.86), corresponding to a sensitivity of 64.2%(95% CI, 49.7-76.5%) and specificity of 82.7%(95% CI, 72.4-89.9%). Host biomarkers detected in QuantiFERON supernatants can contribute to the diagnosis of active TB disease amongst people presenting with symptoms requiring investigation for TB disease, regardless of HIV status or ethnicity in Africa.

Citer ce document

Chegou, N. N., Sutherland, J. S., Namuganga, A. R., Corstjens, P. L. A. M., Geluk, A., Gebremichael, G., Mendy, J., Malherbe, S. T., Stanley, K., Spuy, G. V. D., Kriel, M., Loxton, A. G., Kriel, B., Simukonda, F., Bekele, Y., Sheehama, J., Nelongo, J. N., Vyver, M. V. D., Gebrexabher, A., Hailu, H., Esterhuyse, M. M., Rosenkrands, I., Aagard, C., Kidd, M., Kassa, D., Mihret, A., Howe, R., Cliff, J. M., Crampin, A. C., Mayanja‐Kizza, H., Kaufmann, S. H. E., Dockrell, H. M., Ottenhoff, T. H. M., Walzl, G., McAnda, S., Owolabi, O., Sillah, A. K., Gindeh, A., Donkor, S., Togun, T., Ota, M. O. C., Muzanye, G., Nsereko, M., Peters, P., Fat, E. M. T. K., Dood, C. J. D., Franken, K. L. M. C., Schip, J. J. V. D. P.-V., Gebrezgeabher, A., Mesfin, G., Belay, Y., Alemayehu, Y., Amberbir, A., Chilongo, F., Houben, R. M. G. J., Tessema, B., Yamuah, L., Amutenya, F. N., Monye, L., & Iipinge, S. (2018). Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis. Scientific Reports. https://doi.org/10.1038/s41598-018-20855-7

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 28/08/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations : 2

Téléchargements : 0